Cargando…

Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners

BACKGROUND: Type 2 diabetes mellitus (T2DM), a common chronic health condition, has major health and socioeconomic consequences. In the Indian subcontinent, it is a health condition for which individuals commonly consult Ayurvedic (traditional medical system) practitioners and use their medicines. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Chattopadhyay, Kaushik, Kapoor, Nitin, Heinrich, Michael, Mitra, Achintya, Mittal, Madhukar, Lewis, Sarah Anne, Greenfield, Sheila Margaret, Mukherjee, Shyamalendu, Pischel, Ivo, Jeemon, Panniyammakal, Tandon, Nikhil, Kinra, Sanjay, Biswas, Tuhin Kanti, Leonardi-Bee, Jo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922832/
https://www.ncbi.nlm.nih.gov/pubmed/36793876
http://dx.doi.org/10.3389/fmed.2023.1043715
_version_ 1784887613360963584
author Chattopadhyay, Kaushik
Kapoor, Nitin
Heinrich, Michael
Mitra, Achintya
Mittal, Madhukar
Lewis, Sarah Anne
Greenfield, Sheila Margaret
Mukherjee, Shyamalendu
Pischel, Ivo
Jeemon, Panniyammakal
Tandon, Nikhil
Kinra, Sanjay
Biswas, Tuhin Kanti
Leonardi-Bee, Jo
author_facet Chattopadhyay, Kaushik
Kapoor, Nitin
Heinrich, Michael
Mitra, Achintya
Mittal, Madhukar
Lewis, Sarah Anne
Greenfield, Sheila Margaret
Mukherjee, Shyamalendu
Pischel, Ivo
Jeemon, Panniyammakal
Tandon, Nikhil
Kinra, Sanjay
Biswas, Tuhin Kanti
Leonardi-Bee, Jo
author_sort Chattopadhyay, Kaushik
collection PubMed
description BACKGROUND: Type 2 diabetes mellitus (T2DM), a common chronic health condition, has major health and socioeconomic consequences. In the Indian subcontinent, it is a health condition for which individuals commonly consult Ayurvedic (traditional medical system) practitioners and use their medicines. However, to date, a good quality T2DM clinical guideline for Ayurvedic practitioners, grounded on the best available scientific evidence, is not available. Therefore, the study aimed to systematically develop a clinical guideline for Ayurvedic practitioners to manage T2DM in adults. METHODS: The development work was guided by the UK’s National Institute for Health and Care Excellence (NICE) manual for developing guidelines, the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, and the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument. First, a comprehensive systematic review was conducted which evaluated Ayurvedic medicines’ effectiveness and safety in managing T2DM. In addition, the GRADE approach was used for assessing the certainty of the findings. Next, using the GRADE approach, the Evidence-to-Decision framework was developed, and we focused on glycemic control and adverse events. Subsequently, based on the Evidence-to-Decision framework, a Guideline Development Group of 17 international members made recommendations on Ayurvedic medicines’ effectiveness and safety in T2DM. These recommendations formed the basis of the clinical guideline, and additional generic content and recommendations were adapted from the T2DM Clinical Knowledge Summaries of the Clarity Informatics (UK). The feedback given by the Guideline Development Group on the draft version was used to amend and finalize the clinical guideline. RESULTS: A clinical guideline for managing T2DM in adults by Ayurvedic practitioners was developed, which focuses on how practitioners can provide appropriate care, education, and support for people with T2DM (and their carers and family). The clinical guideline provides information on T2DM, such as its definition, risk factors, prevalence, prognosis, and complications; how it should be diagnosed and managed through lifestyle changes like diet and physical activity and Ayurvedic medicines; how the acute and chronic complications of T2DM should be detected and managed (including referral to specialists); and advice on topics like driving, work, and fasting including during religious/socio-cultural festivals. CONCLUSION: We systematically developed a clinical guideline for Ayurvedic practitioners to manage T2DM in adults.
format Online
Article
Text
id pubmed-9922832
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99228322023-02-14 Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners Chattopadhyay, Kaushik Kapoor, Nitin Heinrich, Michael Mitra, Achintya Mittal, Madhukar Lewis, Sarah Anne Greenfield, Sheila Margaret Mukherjee, Shyamalendu Pischel, Ivo Jeemon, Panniyammakal Tandon, Nikhil Kinra, Sanjay Biswas, Tuhin Kanti Leonardi-Bee, Jo Front Med (Lausanne) Medicine BACKGROUND: Type 2 diabetes mellitus (T2DM), a common chronic health condition, has major health and socioeconomic consequences. In the Indian subcontinent, it is a health condition for which individuals commonly consult Ayurvedic (traditional medical system) practitioners and use their medicines. However, to date, a good quality T2DM clinical guideline for Ayurvedic practitioners, grounded on the best available scientific evidence, is not available. Therefore, the study aimed to systematically develop a clinical guideline for Ayurvedic practitioners to manage T2DM in adults. METHODS: The development work was guided by the UK’s National Institute for Health and Care Excellence (NICE) manual for developing guidelines, the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, and the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument. First, a comprehensive systematic review was conducted which evaluated Ayurvedic medicines’ effectiveness and safety in managing T2DM. In addition, the GRADE approach was used for assessing the certainty of the findings. Next, using the GRADE approach, the Evidence-to-Decision framework was developed, and we focused on glycemic control and adverse events. Subsequently, based on the Evidence-to-Decision framework, a Guideline Development Group of 17 international members made recommendations on Ayurvedic medicines’ effectiveness and safety in T2DM. These recommendations formed the basis of the clinical guideline, and additional generic content and recommendations were adapted from the T2DM Clinical Knowledge Summaries of the Clarity Informatics (UK). The feedback given by the Guideline Development Group on the draft version was used to amend and finalize the clinical guideline. RESULTS: A clinical guideline for managing T2DM in adults by Ayurvedic practitioners was developed, which focuses on how practitioners can provide appropriate care, education, and support for people with T2DM (and their carers and family). The clinical guideline provides information on T2DM, such as its definition, risk factors, prevalence, prognosis, and complications; how it should be diagnosed and managed through lifestyle changes like diet and physical activity and Ayurvedic medicines; how the acute and chronic complications of T2DM should be detected and managed (including referral to specialists); and advice on topics like driving, work, and fasting including during religious/socio-cultural festivals. CONCLUSION: We systematically developed a clinical guideline for Ayurvedic practitioners to manage T2DM in adults. Frontiers Media S.A. 2023-01-30 /pmc/articles/PMC9922832/ /pubmed/36793876 http://dx.doi.org/10.3389/fmed.2023.1043715 Text en Copyright © 2023 Chattopadhyay, Kapoor, Heinrich, Mitra, Mittal, Lewis, Greenfield, Mukherjee, Pischel, Jeemon, Tandon, Kinra, Biswas and Leonardi-Bee. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Chattopadhyay, Kaushik
Kapoor, Nitin
Heinrich, Michael
Mitra, Achintya
Mittal, Madhukar
Lewis, Sarah Anne
Greenfield, Sheila Margaret
Mukherjee, Shyamalendu
Pischel, Ivo
Jeemon, Panniyammakal
Tandon, Nikhil
Kinra, Sanjay
Biswas, Tuhin Kanti
Leonardi-Bee, Jo
Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners
title Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners
title_full Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners
title_fullStr Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners
title_full_unstemmed Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners
title_short Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners
title_sort development process of a clinical guideline to manage type 2 diabetes in adults by ayurvedic practitioners
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922832/
https://www.ncbi.nlm.nih.gov/pubmed/36793876
http://dx.doi.org/10.3389/fmed.2023.1043715
work_keys_str_mv AT chattopadhyaykaushik developmentprocessofaclinicalguidelinetomanagetype2diabetesinadultsbyayurvedicpractitioners
AT kapoornitin developmentprocessofaclinicalguidelinetomanagetype2diabetesinadultsbyayurvedicpractitioners
AT heinrichmichael developmentprocessofaclinicalguidelinetomanagetype2diabetesinadultsbyayurvedicpractitioners
AT mitraachintya developmentprocessofaclinicalguidelinetomanagetype2diabetesinadultsbyayurvedicpractitioners
AT mittalmadhukar developmentprocessofaclinicalguidelinetomanagetype2diabetesinadultsbyayurvedicpractitioners
AT lewissarahanne developmentprocessofaclinicalguidelinetomanagetype2diabetesinadultsbyayurvedicpractitioners
AT greenfieldsheilamargaret developmentprocessofaclinicalguidelinetomanagetype2diabetesinadultsbyayurvedicpractitioners
AT mukherjeeshyamalendu developmentprocessofaclinicalguidelinetomanagetype2diabetesinadultsbyayurvedicpractitioners
AT pischelivo developmentprocessofaclinicalguidelinetomanagetype2diabetesinadultsbyayurvedicpractitioners
AT jeemonpanniyammakal developmentprocessofaclinicalguidelinetomanagetype2diabetesinadultsbyayurvedicpractitioners
AT tandonnikhil developmentprocessofaclinicalguidelinetomanagetype2diabetesinadultsbyayurvedicpractitioners
AT kinrasanjay developmentprocessofaclinicalguidelinetomanagetype2diabetesinadultsbyayurvedicpractitioners
AT biswastuhinkanti developmentprocessofaclinicalguidelinetomanagetype2diabetesinadultsbyayurvedicpractitioners
AT leonardibeejo developmentprocessofaclinicalguidelinetomanagetype2diabetesinadultsbyayurvedicpractitioners